Polysiloxane Gd-Chelates based nanoparticles

基于聚硅氧烷Gd-螯合物的纳米颗粒

Report date: 2026/05/07 20:00:36
NME

Base Information

Drug NamePolysiloxane Gd-Chelates based nanoparticles
Drug Alias NameGadolinium-chelated polysiloxane based nanoparticlesActivation and Guidance of Irradiation X (AGuIX)AGuIX Gadolinium-based NanoparticlesAGuIXAGuIX® nanoparticles +[6] 
ClassificationDiagnostic agent (In vivo)Small molecules
Mechanisms of ActionIonising radiation emittersMagnetic resonance imaging enhancers
TargetsNot applicable
Therapy Area/IndicationsBrain metastasesCarcinoma, Non-Small-Cell LungLung Neoplasms +[11] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItalyFrance
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNh Theraguix Sas
China Registration ClassN/A

Develop Information

Active CompaniesNh Theraguix SasDana-Farber Cancer InstituteThe Brigham and Women's Hospital +[4] 
Inactive CompaniesN/A
Active IndicationsBrain metastasesCarcinoma, Non-Small-Cell LungLung Neoplasms +[11] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A